FTC sues big pharmacy reward managers over insulin price ranges The agency introduced motion in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list cost of daily life-saving insulin drugs. Elevance lowers steerage on ‘unparalleled’ Medicaid challenges Executives stated the https://ayahealthcareaddress84062.qodsblog.com/30654224/the-single-best-strategy-to-use-for-healthcare-news